1. Can Price Transparency Contribute to More Affordable Patient Access to Medicines?

   • Sabine Vogler
   • Kenneth R. Paterson

   Editorial Open access 03 May 2017 Pages: 145 - 147

2. Model-Based Economic Evaluation of Treatments for Depression: A Systematic Literature Review

   • Spyros Kolovos
   • Judith E. Bosmans
   • Maurits W. van Tulder

   Systematic Review Open access 07 February 2017 Pages: 149 - 165

   

3. Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology

   • Kavisha Jayasundara
   • Murray Krahn
   • Paul Grootendorst

   Original Research Article Open access 25 April 2017 Pages: 167 - 173

   

4. Cost-Effectiveness of Haemorrhoidal Artery Ligation versus Rubber Band Ligation for the Treatment of Grade II–III Haemorrhoids: Analysis Using Evidence from the HubBLe Trial

   • Abualbishr Alshreef
   • Allan J. Wailoo
   • Daniel Hind

   Original Research Article Open access 25 April 2017 Pages: 175 - 184

   

5. Evaluating the Treatment Costs for Uncomplicated Malaria at a Public Healthcare Facility in Nigeria and the Implications

   • Charles C. Ezenduka
   • Daniel Resende Falleiros
   • Brian B. Godman

   Original Research Article Open access 10 April 2017 Pages: 185 - 194

   

6. Cost of Illness of Japanese Patients with Chronic Lymphocytic Leukemia (CLL), and Budget Impact of the Market Introduction of Ibrutinib

   • Jörg Mahlich
   • Shinichiro Okamoto
   • Akiko Tsubota

   Original Research Article Open access 27 April 2017 Pages: 195 - 202

   

7. Health System Efficiency: A Fragmented Picture Based on OECD Data

   • Andreas Behr
   • Katja Theune

   Original Research Article Open access 30 January 2017 Pages: 203 - 221

   

8. Cost-Minimisation Analysis of Erythropoiesis-Stimulating Agents in the Treatment of Anaemia in Dialysed Patients: A Pilot Study

   • Astrid Darsonval
   • Virginie Besson
   • Claire Cavalin

   Original Research Article Open access 09 March 2017 Pages: 223 - 229